Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up Women only

Dexamethasone with or without misoprostol to help start labor at term

Official title: Effect of Dexamethasone on Labour Induction in Term Pregnancies

Run by Cairo University · NCT07109258 · Data updated 2026-11-12

This will test whether a dexamethasone shot, alone or with vaginal misoprostol, helps first-time women at term start active labor sooner.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment150 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo, Manial)
StatusRecruiting
StartedMay 1, 2025
Main results expectedSeptember 1, 2025
Study endsSeptember 15, 2025
Registry record updatedAugust 7, 2025
Trial IDNCT07109258 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are first-time mothers over 18 with a singleton, vertex pregnancy at or after 39 weeks who have no contraindication to vaginal delivery.

Probably not a fit

Women with contraindications to vaginal delivery (such as prior cesarean, placenta previa, non-vertex presentation), preterm gestation, fetal macrosomia, or significant maternal medical disorders are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled early phase 1 trial at Cairo University Hospital enrolls nulliparous women at or beyond 39 weeks with a singleton, vertex pregnancy who are eligible for induction. Participants are randomly assigned to one of three groups: a single intramuscular 8 mg dose of dexamethasone, vaginal misoprostol 25 μg every 6 hours (up to four doses), or dexamethasone given with the first misoprostol dose. The primary outcome is time from initiation of induction to the beginning of the active phase of labor, with secondary outcomes including duration of active labor, second stage length, mode of delivery, and fetal outcomes. Clinical assessment includes Bishop score, fetal biophysical profile, and inpatient monitoring during induction as per protocol.

Why it matters

Potential benefit: If successful, the intervention could shorten the time from induction to active labor and may reduce prolonged inductions or emergency cesarean deliveries.

How similar studies have gone: Vaginal misoprostol is an established induction method, but using dexamethasone alone or combined with misoprostol for induction is relatively novel with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years.
* Nulliparous.
* Vertex presentation.
* Singleton pregnancy.
* Gestational age ≥ 39 weeks according to a reliable date for the last menstrual period or a first-trimester ultrasound evaluation.
* No contraindication for vaginal delivery.

Exclusion Criteria:

* Indication for cesarean section e. g. Placenta previa, intrauterine growth retardation, non-vertex presentation and previous cesarean section.
* Maternal medical disorders as diabetes mellitus and severe pre-eclampsia.
* Preterm labour and preterm rupture of membranes.
* Gestational age \<39 weeks of gestation.
* Fetal macrosomia \> 4kg (estimated by u/s).

Where it's running

  • Cairo University Hospital (Kasr Al Ainy)
    Cairo, Manial, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.